MedTrace Logo

18F-FAPI PET Imaging in Pancreatic Adenocarcinoma

NCT05884463 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2023-06-01

No results posted yet for this study

Summary

To explore the potential efficacy of 18F-FAPI-04 PET/CT for PDAC tumour staging and compare the results with those obtained using 18F-FDG PET/CT.

Conditions

  • 18F-FAPI
  • 18F-FDG
  • Pancreas Adenocarcinoma
  • Diagnosis
  • Staging

Interventions

DRUG

18F-FAPI

Intravenous injection of one dosage of 18F-FAPI.

DRUG

18F-FDG

Intravenous injection of one dosage of 18F-FDG.

Sponsors & Collaborators

  • Zhejiang University

    lead OTHER

Principal Investigators

  • Tingbo Liang, Ph.D., M.D. · Zhejiang University

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2023-02-28
Completion
2023-02-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05884463 on ClinicalTrials.gov